Defence Therapeutics Inc.: Defence Therapeutics Signs an Agreement with Biopharma Excellence, a Pharmalex GmbH Company, to Maximize and Strategize the Development of Its Accum Platform and Clinical Trials
Defence or the
Company ), a biotechnology company working on cancer therapeutics and infectious disease vaccines is pleased to announce the agreement with the German renowned pharmaceutical consulting and advisory company, Pharmalex GmbH, through Biopharma Excellence.
With more than 35,000 successful projects completed, Pharmalex GmbH is a leading provider of specialized services for the pharmaceuticals, biotech and medical device industries that prioritize compliance. Biopharma Excellence, a Pharmalex GmbH division, is a leading pharmaceutical consultancy company with expertise covering all areas from development to approval and partnering of biopharmaceuticals with a focus on Europe, United States and Japan regulatory affairs.
Germany
Japan
United-states
United-kingdom
London
City-of
Vancouver
British-columbia
Canada
British
German
Michael-pfleiderer